Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors
Go back to Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors| DaVita Inc. (NYSE: DVA) | Delayed: 209.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.68 | 52 Week High | $78.77 | |||
| Open | $209.68 | 52 Week Low | $55.00 | |||
| Day High | $209.68 | P/E | 72.55 | |||
| Day Low | $209.68 | EPS | $2.89 | |||
| Volume | 43 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $45.34 | |||
| Open | $4.50 | 52 Week Low | $15.92 | |||
| Day High | $4.50 | P/E | 1.93 | |||
| Day Low | $4.50 | EPS | $2.33 | |||
| Volume | 20 | |||||
